(HealthDay)—Life expectancy in the United States has declined for two years in a row, fueled by increasing death rates from
Continue reading »
Zika virus targets brain cancer in vaccine study
Study tracks health of babies born to Zika-infected mothers CDC study found one in seven children born to mothers infected
Continue reading »
Second HPV-related primary cancers common in survivors
(HealthDay)—The risk of human papillomavirus-associated second primary cancers (HPV-SPCs) among survivors of HPV-associated cancers is significant, according to a study
Continue reading »
Tips for advising patients living in highly polluted settings
(HealthDay)—Clinicians advising families living overseas in highly polluted settings should understand their patients’ concerns and have a network of resources
Continue reading »
Antipsychotic drugs are rarely effective in ‘calming’ dementia patients
Antipsychotic medications were initially developed to treat schizophrenia, a mental health condition characterised by psychotic symptoms such as delusions and
Continue reading »
Study reveals the current rates of diagnosed type 1 and type 2 diabetes in American adults
A new study from the University of Iowa finds that type 2 diabetes remains overwhelmingly the most common type of
Continue reading »
The six types of teenage spirituality in Australia
The 2016 Census suggested about a third of Australian teens had no religion. But ask a teenager themselves about religion,
Continue reading »
Being forgotten by acquaintances can affect self-esteem in the same way as being rejected
Psychologists at The University of Aberdeen looking into the experience of being forgotten have discovered that memory lapses can damage
Continue reading »
Daily low-dose aspirin found to have no effect on healthy life span in older people
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without
Continue reading »
Small reduction in lung function with Tx de-escalation in COPD
(HealthDay)—A de-escalation from triple therapy to indacaterol/glycopyrronium may lead to a small reduction in lung function in non-frequently exacerbating patients
Continue reading »